Equities Research Analysts’ price target changes for Wednesday, August 16th:
Agilent Technologies (NYSE:A) had its price target increased by Janney Montgomery Scott from $65.00 to $70.00. The firm currently has a buy rating on the stock.
Agilent Technologies (NYSE:A) was given a $68.00 price target by analysts at Deutsche Bank AG. The firm currently has a buy rating on the stock.
Autodesk (NASDAQ:ADSK) had its price target boosted by Robert W. Baird from $110.00 to $120.00. Robert W. Baird currently has an outperform rating on the stock.
Brookfield Business Partners L.P. (NYSE:BBU) had its target price boosted by Brookfield Business Partners LP to $43.00. They currently have an outperform rating on the stock.
Brookfield Renewable Partners L.P. (NYSE:BEP) (TSE:BEP) had its price target increased by Brookfield Renewable Partners LP to $48.50. The firm currently has a buy rating on the stock.
Fairfax Financial Holdings (TSE:FFH) had its target price increased by Fairfax Financial Holdings Ltd. from C$525.00 to C$550.00. Fairfax Financial Holdings Ltd. currently has an outperform rating on the stock.
Lion Biotechnologies (NASDAQ:IOVA) was given a $16.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.
Mesoblast Limited (NASDAQ:MESO) was given a $14.00 price target by analysts at Maxim Group. The firm currently has a buy rating on the stock.
Pluristem Therapeutics (NASDAQ:PSTI) was given a $2.00 target price by analysts at Maxim Group. The firm currently has a buy rating on the stock.
Seattle Genetics (NASDAQ:SGEN) was given a $46.00 price target by analysts at Cantor Fitzgerald. The firm currently has a hold rating on the stock.
Theravance Biopharma (NASDAQ:TBPH) was given a $55.00 target price by analysts at Cantor Fitzgerald. The firm currently has a buy rating on the stock.
TrovaGene (NASDAQ:TROV) was given a $4.00 target price by analysts at Maxim Group. The firm currently has a buy rating on the stock.
Urban Outfitters (NASDAQ:URBN) was given a $16.00 price target by analysts at MKM Partners. The firm currently has a sell rating on the stock.
Vantiv (NYSE:VNTV) had its price target raised by Oppenheimer Holdings, Inc. from $70.00 to $77.00. The firm currently has an outperform rating on the stock.
